selective serotonin reuptake inhibitor (SSRI)

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:sertraline_hydrochloride
gptkb:Citalopram
gptkb:Fluoxetine
gptkb:Sertraline
gptkbp:activities inhibiting serotonin reuptake
gptkbp:affects increased risk of bleeding
possible weight changes
potential serotonin syndrome
gptkbp:can_be gptkb:psychologist
support groups
lifestyle changes
gptkbp:contraindication MAO inhibitors
gptkbp:discovered_by 1970s
gptkbp:example gptkb:citalopram
gptkb:escitalopram
gptkb:paroxetine
fluoxetine
sertraline
https://www.w3.org/2000/01/rdf-schema#label selective serotonin reuptake inhibitor (SSRI)
gptkbp:influences mood
sleep patterns
appetite
emotional state
anxiety levels
gptkbp:interacts_with gptkb:beer
blood thinners
other antidepressants
NSAI Ds
st. john's wort
gptkbp:is_available_on generic medication
brand name medication
gptkbp:is_effective_against chronic pain
schizophrenia
ADHD
substance use disorders
some anxiety disorders
gptkbp:is_monitored_by side effects
suicidal thoughts
serotonin syndrome
gptkbp:is_used_by psychiatrists
gptkbp:is_used_for gptkb:historical_event
anxiety disorders
gptkbp:side_effect nausea
insomnia
weight gain
sexual dysfunction
gptkbp:suitable_for bipolar disorder
severe liver disease
gptkbp:symptoms dizziness
irritability
flu-like symptoms